Funded Startups in Kauno Apskritis
Across the 14 most recent Kauno Apskritis entries, the largest disclosed round is PVcase at $100M (2023-07-18), which dwarfs the next-largest disclosed amo…
Across the 14 most recent Kauno Apskritis entries, the largest disclosed round is PVcase at $100M (2023-07-18), which dwarfs the next-largest disclosed amounts: Sentante at $7M (2023-12-21) and Eneba at $7M (2020-12-21). Most other disclosed rounds sit below that, with multiple sub-$1M rounds such as Biohifas at $30K (2024-02-15) and ColibrisODM at $320K (2023-05-18).
The timing clusters strongly: 5 of 14 rounds close between 2023-05-18 and 2024-01-01 (including ColibrisODM $320K on 2023-05-18, PVcase $100M on 2023-07-18, Sentante $7M on 2023-12-21, and LupaSearch $220K on 2024-01-01). Stage labeling is also uneven, with 5 of 14 entries marked “Series Unknown” or blank (Biohifas $30K, ColibrisODM $320K, BitDegree undisclosed, DappRadar $5M, and Eneba $7M), while the most recent round shown is BrachyDOSE (Seed) at $650K on 2025-07-10 and the oldest is Eneba at $7M on 2020-12-21.
Most recent rounds
14 shownRelated listings
Frequently asked
What stands out as the largest disclosed funding in Kauno Apskritis, and how does it compare to the rest of the disclosed rounds?
PVcase’s $100M round on 2023-07-18 is the only disclosed amount in the $50M+ range; the next-largest disclosed rounds are tied at $7M (Sentante on 2023-12-21 and Eneba on 2020-12-21). Everything else shown is below $7M, including multiple rounds at or under $2M such as Sort A Brick $2M (2025-05-13) and Frontu $600K (2021-08-24).
Is there a concentration of funding dates in a specific window among the 14 most recent entries?
Yes. Five of the 14 rows fall between 2023-05-18 and 2024-01-01, spanning ColibrisODM $320K (2023-05-18), PVcase $100M (2023-07-18), Sentante $7M (2023-12-21), and LupaSearch $220K (2024-01-01), with Vilimed also in that broader cluster at $320K on 2022-12-29. Outside that window, funding appears more sporadic across 2020–2025 (e.g., BrachyDOSE on 2025-07-10 and Eneba on 2020-12-21).
How often is stage information missing or labeled “Series Unknown/blank,” and does that affect which high-value rounds are easier to benchmark?
Stage is unspecified in 5 of 14 rows: Biohifas ($30K, 2024-02-15) and ColibrisODM ($320K, 2023-05-18) are “Series Unknown,” BitDegree (undisclosed, 2022-07-29) is “Series A” but undisclosed amount, and DappRadar ($5M, 2021-05-07) and Eneba ($7M, 2020-12-21) show blank stage. By contrast, the top disclosed outlier PVcase is clearly labeled “Series B” at $100M (2023-07-18).
Which sectors are most represented across this slice of Kauno Apskritis rounds?
Health Care is the most repeated sector with 3 entries: BrachyDOSE (Seed, $650K on 2025-07-10), Biohifas (Series Unknown, $30K on 2024-02-15), and Vilimed (Seed, $320K on 2022-12-29). Other sectors appear once or twice, such as Energy (PVcase only at $100M on 2023-07-18) and Hardware (Sentante only at $7M on 2023-12-21).
Which entries fall closest to the most recent round date shown, and do they skew larger or smaller than earlier rounds?
Relative to the latest date in the list (BrachyDOSE on 2025-07-10), the closest rounds are Sort A Brick at $2M (2025-05-13) and then a larger gap back to 2024-02-15 (Biohifas at $30K) and 2024-01-01 (LupaSearch at $220K). In that immediate late-2024 to mid-2025 cluster, disclosed amounts range from $30K to $2M, which is materially below the earlier disclosed peak of $100M (PVcase on 2023-07-18).
Are there any clear outliers besides the largest round, based on exceptionally small or undisclosed amounts?
Yes. Biohifas at $30K on 2024-02-15 is the smallest disclosed amount in the table, and BitDegree is an additional outlier because the amount is “undisclosed” on 2022-07-29. Compared with other early-to-mid range disclosed rounds like Contribee $200K (2021-08-11) and Frontu $600K (2021-08-24), Biohifas is dramatically smaller on disclosed funding.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.